Effects of Metreleptin in Type 1 Diabetes Mellitus
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study will add leptin therapy to the current insulin therapy of Type 1 Diabetics with
the aim of lowering the total insulin requirements and suppressing the steep fluctuations
typically associated with Type 1 Diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborators:
Amylin Pharmaceuticals, LLC. Juvenile Diabetes Research Foundation